Answers from the Lab

The Centers for Disease Control and Prevention (CDC) issued a recent health advisory to remind healthcare providers to be on the lookout for cases of measles and to educate patients on measles prevention.  In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Matthew Binnicker, Ph. D., director o...

John Lieske, M.D., explains why it's now easier for clinicians to pull information from Mayo Clinic Laboratories' urine supersaturation test report. An updated format summarizes complex information to help guide the treatment of kidney stones. (00:32)  Could you tell us a little bit about yourself and your background?   (01:28)  Could you give us a brief overview of urine supersaturation testing?...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to discuss the latest update on the U.S. Food and Drug Administration’s (FDA) proposed rule to oversee laboratory-developed tests (LDTs) and what that could mean f...

Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC, explain how Mayo Clinic Laboratories' multigene panel helps identify the cause of hereditary ataxia. Precise diagnosis of this complex movement disorder helps guide patient treatment and family screening. Show notes Speaker 3: (00:31)  Can you tell us a little about yourselves and your backgrounds?   Speaker 3: (01:33)  Why is genetic counseli...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to talk about the evolution of remote diagnostics and how Mayo Clinic’s remote cardiovascular monitoring services empower physicians and patients.  Specific topics...

Anne Tebo, Ph. D., explains how Mayo Clinic Laboratories' updated ALDG2 assay helps with the evaluation of patients with suspected autoimmune liver disease. The panel also helps with the evaluation of liver disease of unknown etiology. Speaker 2: (00:32)  Could you provide a little bit about you and your background?   Speaker 2: (02:05)  Can you please give a brief overview of this assay?   Speake...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to talk about the tick season peak that parts of the United States are experiencing, and how to diagnose and prevent Lyme disease. Specific topics of discussion in...

Research and discoveries in the biopharmaceutical industry drive health care innovation and lead to new therapies for patients. When laboratories collaborate with biopharma, diagnostic, and biotech companies, it creates an integrated diagnostic ecosystem that can improve global health. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine...

Artificial intelligence (AI) can be an excellent tool for enhancing patient care and streamlining efficiencies in the lab. But because of its potential risks, AI must be thoughtfully and responsibly applied, both now and in the future.  In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Willia...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Elitza Theel, Ph. D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, talk about West Nile virus and why laboratories and the public need to be aware as mosquitoes reemerge. Specific topics of discussion include: Why the mosquit...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to discuss broader changes that are unfolding in the national and global diagnostic industry, and what to expect in the coming years. Specific topics of discussion...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Elitza Theel, Ph. D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, discuss endemic fungal infections that can be found in North America, specifically blastomycosis and histoplasmosis.  Specific topics of discussion include: T...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, and special guest Susan Van Meter, president of the American Clinical Laboratory Association (ACLA). In celebration of Medical Laboratory Professionals Week, they...

Sean Pittock, M.D., explains how Mayo Clinic Laboratories' novel Ma2 test aids diagnosis of autoimmune neurology disorders that are often caused by underlying cancer. Rapid diagnosis is key to preventing significant disability and disease. (00:31)  Can you provide our listeners with a little bit of background on your role at Mayo Clinic?   (01:56)  Is Ma2 an example of identifying a need in patien...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Nancy Wengenack, Ph. D., director of the Mycology and Mycobacteriology Laboratories at Mayo Clinic, discuss the increased focus on fungi and why emerging fungal infections can be concerning for health care facilities. Specific topics of discussion incl...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and William Morice II, M.D., Ph. D., president and CEO of Mayo Clinic Laboratories, discuss how representation and advocacy make a difference in regulatory outcomes. Specific topics of discussion include:  Why pathologists should be leading conversations a...

Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test speeds therapeutic decision making for adults with acute myeloid leukemia, or AML. The standalone assay yields faster results than next generation sequencing. (00:32)  Would you provide a brief background of yourself?   (01:42)  Could you give an overview of the IDHQ test?   (02:25)  Is there anything more you'd like to touch on about...

In this test-specific episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Bjorn Oskarsson, M.D., a neurologist at Mayo Clinic’s Florida campus, discuss how the neurofilament light chain test available through Mayo Clinic Laboratories helps physicians diagnose neurological disease and assess neuronal damage. Spe...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and William Morice II, M.D., Ph. D., president and CEO of Mayo Clinic Laboratories, discuss the increasing rates of tick-borne diseases and how to test for and prevent them. They also discuss what to watch from a federal legislative standpoint now that Con...

Elitza Theel, Ph. D., explains how Mayo Clinic Laboratories' unique Histoplasma and Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and Blastomyces pathogens in a single test. (00:32) Will you please give us a brief introduction of yourself and your role at Mayo Clinic?   (01:34)  Can you tell us wh...

Zhiyv (Neal) Niu, Ph. D., and Rodolfo Savica, M.D., Ph. D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the condition — or increase the risk of developing it. (01:37)  Can you give us a brief overview of the inherited Parkinson's disease gene panel, and when it would b...

(00:31)  Dr. Niu, could you provide us with a little bit of your background? (01:03)  Dr. Klein, could you provide us with a little bit of your background?   (01:40)  Would you give us a brief overview of the new panel?   (02:49)  Dr. Klein, could you give us a simple background of what you see going on in this space?   (03:33)  Which patients should have this testing, and when should it be perfor...

Many laboratorians are not patient-facing. So, while laboratories are critical to patient care, they may lack visibility when it comes to policymaking.  In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and William Morice II, M.D., Ph. D., president and CEO of Mayo Clinic Laboratories, discuss their leade...

(00:31)  Would each of you share a little bit about yourselves and your backgrounds?   (01:47)  Could you provide us with an overview of what the WGSDX test is?   (02:26)  How is that different from other genetic tests, like exome or microarray?   (03:56)  Tell us more about who benefits from these tests.   (07:17)  Is this test recommended by expert groups?   (09:10)  How do providers go about or...